A First-Hand Account of 3PLs – A Podcast on Distribution Best Practices

A First-Hand Account of 3PLs – A Podcast on Distribution Best Practices
A First-Hand Account of 3PLs and the Factors That Manufacturers Should Consider
Listen to the podcast on The Pharmaceutical Commerce website.
Rob Besse, Vice President of Archbow Consulting, joins Pharmaceutical Commerce Editor Nicholas Saraceno to share a general overview of how the 3PL process works, using his 20-plus years of pharmaceutical supply chain experience. Highlights of the Podcast include:
- The factors that manufacturers should consider when selecting a 3PL, along with the array of services that a quality 3PL should provide
- Valuable lessons he believes 3PLs learned during the COVID-19 pandemic that have helped improve efficiencies
- Trends affecting the pharma industry that 3PLs should be on the lookout for the rest of the year
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud. Listen to the podcast on The Pharmaceutical Commerce website.
Contact us today if we can help you with your next 3PL or distribution program.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Revolutionizing Patient Support: The Power of a Seamless Product Access Framework
Why Understanding the Product Access Journey is Essential for Patient Support Success
2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
Fair Market Value vs. Current Market Leverage
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|